Jobs
View more job listings or post a job
Genentech Scientist, DMPK
Pliant Therapeutics, Inc. Associate Director/ Director, Formulation Development
AbVision Inc. Research Scientist (Immunology/Cell Biology, all levels available)
Regulus Therapeutics Senior Research Associate/Scientist, Drug Metabolism and Pharmacokinetics
Aligos Therapeutics Principal Research Scientist, DMPK
PPD, Inc. Senior Scientist - Quality Control - HPLC - Dissolution - Method Validation
Aligos Therapeutics Director DMPK
Genentech Senior Scientific Researcher, DMPK
Genentech Scientist/Sr. Scientist Small Molecule - In Vitro DMPK
Post a job

Symposium

Immuno-Oncology: Advances in Translating from Bench to Clinic


Speakers: Luis Borges, Deborah Charych, Ravi Majeti, Brian Wong, Juan Jaen, Tara Arvedson, Jason DeVoss, Lelia Delamarre, Cheng Liu
Organizers: Snow Ge (Nektar), Deborah Charych (Nektar), Wenfeng Xu (Genentech)
Date: 2017-06-28
Time: 8:45-17:00 Pacific Time
Registration fee (USD): Regular: $195; Academic: $125; Students & Unemployed: $35
Location: Crowne Plaza, Foster City, CA
Major Sponsor: (2)Celerion; Charles River
Vendor show vendors registered to date: (23)Applied BioMath; Aragen Bioscience, Inc.; BioLegend; Bio-Techne; Cardinal Health; Cellular Dynamics Intl; Covance; CrownBio; Cytovier LLC; Eurofins; Eurofins Pharma Discovery Services; Fujifilm Diosynth Biotechnologies; Intertek; PeproTech Inc; PharmaLegacy; PHARMout Laboratories; PPD; Premier Research; Quintara; Science Exchange; Second Genome; ThermoFisher; WuXi Apptec
Registration: http://www.PBSS.org
Registration deadline:2017-06-27  (it will close sooner if the seating cap is reached)

About the Topic

8:45-8:55  Opening Remarks and Introduction

8:55-9:35  Discovery of new drug targets and therapeutic approaches for cancer immunotherapy (Luis Borges, SVP, Five Prime Therapeutics)

9:35-10:15  Harnessing the Potent IL2 Immune Stimulatory Pathway with Designer Polymers (Deborah Charych, ED, Nektar)

10:15-10:25  Major sponsor presentation (Charles River)

10:25-10:40  Break

10:40-11:20  Pre-Clinical Development of a Humanized Anti-CD47 Antibody (Ravi Majeti, Professor, Stanford)

11:20-12:00  Discovery and development of orally-available cancer immunotherapies (Brian Wong, CEO, FLX Bio)

12:00-1:00  Lunch

1:00-1:40  Small Molecules, Antibodies, and Cell-based Therapies in the Fight Against Cancer (Juan Jaen, Founder and President, Arcus Biosciences and PACT Pharma)

1:40-2:20  Blincyto and BiTE® Antibody Platform for Cancer Therapy (Tara Arvedson, Principal Scientist, Amgen)

2:20-2:30  Major sponsor presentation (Celerion)

2:30-2:45  Break

2:45-3:25  T-VEC and oncolytic therapy (Jason DeVoss, Sr. Scientist, Amgen)

3:25-4:05  Personalized Cancer Vaccine (Lelia Delamarre, Sr. Scientist, Genentech)

4:05-4:15  Break

4:15-4:55  After CD19: CAR-T for solid tumor (Cheng Liu, CEO, Eureka)

4:55-5:15  General Q&A


2019-07-26, Generating Efficacious Enzyme Therapeutics based on Knowledge Learned From Biocatalytic Pharmaceutical Manufacture
2019-09-13, Biotransformation and Disposition of Larger Molecules: Peptides, Nucleotides, Proteins, mAbs, and ADCs
2019-10-03, Small-Molecule Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends
2019-10-18, Physiologically Based Pharmacokinetic (PBPK) Modeling: Fundamentals, Regulatory Guidance & Applications
2019-11-12, Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
2019-12-10, In vitro Diagnostics and Precision Medicine
2020-02-11, Drug-Device Combination
┬ęPharmaceutical & BioScience Society, International; Last Modified: 6/26/2019; Visited: 1004; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Immunomind Scientific Consulting - Protocol Development, Data Analysis, Lab Guidance, Tech Transfer - Meeting your project goals at a moment's notice.
Hypha Discovery mg-g scale synthesis/purification of CYP/non-CYP metabolites including glucuronides. Plus NEW PolyCYPs kits for in-house synthesis of CYP metabolites.
Pacific BioLabs CRO in Bay Area - PK, toxicology, biocompatibility, analytical chemistry, immunogenicity, biomarker analysis, stability studies, sterility, endotoxin
Submit a Text Ad